laboratoryacquir
infect
lai
caus
accident
exposur
infecti
aerosol
contact
mucou
membran
even
though
lai
decreas
due
person
protect
measur
biosafeti
train
pike
et
al
report
lai
result
death
occur
unit
state
thereaft
hard
byer
identifi
lai
result
death
accord
siengsananlamont
et
al
lai
occur
asiapacif
region
instanc
lai
caus
brucella
spp
chlamydia
psittaci
coccidioid
immiti
coxiella
burnetii
francisella
tularensi
mycobacterium
tuberculosi
salmonella
enterica
blastomyc
dermatitidi
dengu
viru
hepat
b
viru
venezuelan
equin
enceph
viru
howev
caus
mani
case
lai
clearli
identifi
past
recent
detail
caus
lai
investig
two
laboratori
worker
nation
institut
virolog
laboratori
chines
center
diseas
control
prevent
beij
china
infect
sever
acut
respiratori
syndrom
coronaviru
sarscov
due
handl
incomplet
inact
viru
thought
two
individu
sourc
subsequ
small
outbreak
sar
center
diseas
control
prevent
atlanta
ga
usa
announc
approxim
staff
member
expos
bacillu
anthraci
sampl
analyz
matrixassist
laser
desorpt
ionizationtim
flight
mass
spectrometri
transfer
incomplet
inactiv
sampl
biosafeti
level
bsl
facil
lower
bsl
facil
three
research
boston
univers
develop
tularemia
accident
exposur
f
tularensi
supposedli
due
failur
compli
safeti
protocol
consid
accident
infect
sarscov
b
anthraci
f
tularensi
laboratori
worker
pay
care
attent
handl
pathogen
therefor
seem
necessari
educ
staff
member
method
complet
inactiv
pathogen
pathogen
microorgan
pose
threat
public
health
categor
four
risk
group
accord
laboratori
biosafeti
manual
publish
world
health
organ
geneva
switzerland
nation
institut
health
nih
biotechnolog
activ
bethesda
md
usa
public
titl
nih
guidelin
research
involv
recombin
synthet
nucleic
acid
molecul
nih
guidelin
biosafeti
microbiolog
biomed
laboratori
guid
us
depart
health
human
servic
center
diseas
control
prevent
nih
usa
direct
european
parliament
council
septemb
protect
worker
risk
relat
exposur
biolog
agent
work
guidelin
obey
laboratori
world
revis
base
histor
incid
accident
infect
experi
research
summar
kimman
et
al
japan
select
agent
toxin
strictli
classifi
accord
act
prevent
infecti
diseas
medic
care
patient
infecti
diseas
adopt
ministri
health
labour
welfar
pathogen
handl
nation
institut
infecti
diseas
niid
classifi
risk
group
determin
biorisk
committe
experi
conduct
risk
group
pathogen
must
perform
facil
accord
regul
stipul
niid
japan
prevent
accident
infect
sampl
prepar
facil
requir
complet
inactiv
sampl
handl
outsid
facil
lower
bsl
f
tularensi
gramneg
facult
intracellular
bacterium
classifi
four
subspeci
subsp
tularensi
holarctica
mediasiatica
novicida
four
subspeci
f
tularensi
subsp
tularensi
first
identifi
north
america
pathogen
human
anim
infecti
dose
extrem
low
colonyform
unit
cfu
untreat
antibiot
mortal
rate
extrem
high
around
f
tularensi
subsp
holarctica
mediasiatica
intermedi
virul
low
mortal
rate
wherea
infect
subsp
novicida
detect
immunocompromis
human
japan
vitro
vivo
bacteriolog
procedur
involv
f
tularensi
except
subsp
holarctica
live
vaccin
strain
lv
subsp
tularensi
strain
subsp
novicida
must
conduct
facil
sever
establish
chemic
physiolog
techniqu
inact
pathogen
f
tularensi
form
spore
inactiv
conduct
common
method
treatment
heat
paraformaldehyd
pfa
phosphatebuff
salin
pb
overnight
pfa
glutaraldehyd
sodium
cacodyl
formaldehyd
combin
sodium
hypochlorit
follow
ethanol
ultraviolet
uv
radiat
f
tularensi
subsp
tularensi
schu
dri
acryl
glass
polyamid
polyethylen
polypropylen
silicon
rubber
stainless
steel
easili
inactiv
exposur
vapor
hydrogen
peroxid
f
tularensi
schu
dri
wood
would
inactiv
hardli
bleach
citric
acid
ethanol
quaternari
ammonia
pinesol
bone
marrowderiv
macrophag
infect
f
tularensi
schu
complet
fix
pfa
min
pfa
min
wherea
treatment
pfa
h
fail
inact
infect
cell
howev
method
inactiv
f
tularensi
differ
among
report
therefor
present
studi
aim
confirm
treatment
condit
safe
complet
inactiv
f
tularensi
comprehens
comparison
cultur
bacteria
treat
control
sampl
f
tularensi
subsp
tularensi
schu
establish
previou
studi
cultur
chemic
defin
medium
cdm
late
logarithm
phase
f
tularensi
subsp
tularensi
nevada
subsp
holarctica
lv
kato
yama
kf
water
kindli
provid
dr
h
fujita
ohara
research
laboratori
ohara
gener
hospit
fukushima
japan
list
tabl
cultur
condit
f
tularensi
schu
centrifug
g
min
bacteri
pellet
resuspend
cdm
contain
glycerol
store
use
procedur
regard
live
bacteri
cultur
perform
facil
accord
regul
establish
niid
japan
five
microlit
f
tularensi
schu
averag
cfu
suspend
deioniz
water
cdm
undilut
fetal
bovin
serum
fb
biosera
franc
incub
incub
min
h
day
week
serial
dilut
bacteri
sampl
cultur
eugon
chocol
agar
plate
day
averag
cfu
number
calcul
averag
number
coloni
four
replic
sampl
five
microlit
f
tularensi
schu
averag
cfu
suspend
deioniz
water
cdm
pb
sigmaaldrich
corpor
st
loui
mo
usa
undilut
fb
ad
ml
pcr
tube
biobik
ina
optica
nagano
japan
incub
use
astec
thermal
cycler
astec
co
ltd
fukuoka
japan
control
sampl
incub
indic
incub
time
serial
dilut
bacteri
sampl
cultur
eugon
chocol
agar
plate
day
averag
cfu
number
calcul
averag
number
coloni
four
replic
sampl
fifti
microlit
f
tularensi
schu
averag
cfu
suspend
ml
cdm
screen
millipor
pvdf
hydrophil
millexhv
steril
syring
filter
unit
micron
emd
millipor
corpor
billerica
usa
micron
emd
millipor
corpor
filtrat
sampl
serial
dilut
cultur
eugon
chocol
agar
plate
day
averag
cfu
number
calcul
averag
number
coloni
four
replic
sampl
five
microlit
f
tularensi
schu
averag
cfu
suspend
cdm
centrifug
g
min
supernat
transfer
new
tube
remain
pellet
resuspend
cdm
sampl
serial
dilut
cultur
eugon
chocol
agar
plate
day
averag
cfu
number
calcul
averag
number
coloni
four
replic
sampl
five
microlit
f
tularensi
schu
mix
deioniz
water
ethanol
sigmaaldrich
methanol
nacalai
tesqu
inc
kyoto
japan
aceton
sigmaaldrich
mixtur
methanol
aceton
formaldehyd
neutral
buffer
solut
wako
pure
chemic
industri
ltd
osaka
japan
pfa
wako
acetonitril
sigmaaldrich
final
concentr
sodium
hypochlorit
purelux
oyalox
co
ltd
tokyo
japan
incub
min
room
temperatur
five
microlit
f
tularensi
schu
mix
triton
ld
nacalai
tesqu
buffer
supplement
sodium
dodecyl
sulphat
buffer
glycerol
wako
bromophenol
blue
mm
trishcl
ph
wako
mixtur
deterg
bacteria
incub
min
h
h
sampl
centrifug
g
min
afterward
supernat
discard
remov
effect
solvent
bacteri
pellet
resuspend
cdm
viabl
bacteria
count
experi
conduct
use
four
replic
fifti
microlit
f
tularensi
schu
ad
ml
cdm
undilut
fb
roswel
park
memori
institut
rpmi
medium
contain
fb
without
deterg
bacteri
suspens
put
ml
tube
contain
mm
ceram
sphere
mp
biomed
illkirchgraffenstaden
franc
lyse
matrix
garnet
mp
biomed
shaken
period
rpm
mini
bead
beater
biospec
product
inc
bartlesvil
ok
usa
immedi
cool
ice
live
bacteria
aliquot
enumer
experi
conduct
use
four
replic
inact
effect
cell
lysi
buffer
cell
signal
technolog
danver
usa
examin
nineti
microlit
f
tularensi
schu
averag
cfu
mix
ten
microlit
cell
lysi
buffer
cell
signal
technolog
cdm
ad
bacteria
control
sampl
sampl
incub
min
bacteri
viabil
suspend
rlt
buffer
suppli
rneasi
mini
kit
evalu
bacteri
pellet
averag
cfu
centrifug
g
min
suspend
rlt
buffer
alon
mixtur
equal
volum
rlt
buffer
ethanol
cdm
control
sampl
sampl
incub
room
temperatur
min
experi
sampl
incub
centrifug
g
min
remov
commerci
buffer
pellet
contain
live
bacteria
suspend
cdm
cfu
count
experi
conduct
use
four
replic
five
microlit
f
tularensi
schu
spike
deioniz
water
cdm
undilut
fb
transfer
ml
tube
sarstedt
kk
tokyo
japan
ml
pcr
tube
biobik
ina
optica
sampl
radiat
room
temperatur
use
funauvlink
funakoshi
tokyo
japan
equip
lowpressur
lamp
nm
averag
uv
energi
monitor
sensor
system
experi
radiat
cfu
sampl
measur
experi
conduct
use
four
replic
five
f
tularensi
strain
subsp
tularensi
nevada
subsp
holarctica
lv
kato
yama
kf
water
prepar
valid
effect
inactiv
f
tularensi
bacteria
heat
min
min
filter
use
millipor
pvdf
hydrophil
millexhv
steril
syring
filter
unit
micron
emd
millipor
corpor
micron
emd
millipor
corpor
incub
h
deterg
ld
buffer
radiat
room
temperatur
lowpressur
lamp
nm
procedur
accord
condit
treatment
f
tularensi
schu
cfu
untreat
treat
sampl
compar
experi
conduct
four
replic
statist
analys
perform
use
graphpad
prism
softwar
graphpad
softwar
inc
la
jolla
ca
usa
experi
studi
perform
use
four
replic
result
express
mean
number
cfu
sd
signific
differ
cfu
heatdenatur
sampl
control
sampl
determin
use
student
ttest
comparison
cfu
treat
control
sampl
perform
use
oneway
twoway
analysi
varianc
anova
signific
differ
found
comparison
made
use
bonferroni
post
hoc
test
evalu
stabil
f
tularensi
schu
bacteria
suspend
deioniz
water
undilut
fb
chemic
defin
medium
cdm
f
tularensi
incub
respect
deioniz
water
number
live
bacteria
approxim
cfu
min
significantli
differ
h
p
thereaft
bacteria
incub
week
w
week
day
detect
fig
cdm
often
use
liquid
cultur
f
tularensi
promot
longterm
bacteri
viabil
fig
f
tularensi
schu
suspend
undilut
fb
bacteri
viabil
slightli
improv
deioniz
water
fig
bacteri
viabil
strain
affect
short
incub
less
h
signific
chang
number
cfu
detect
min
h
p
heat
treatment
wide
use
complet
inactiv
bacteria
henc
thermal
resist
f
tularensi
schu
examin
studi
bacteri
suspens
deioniz
water
cdm
undilut
fb
contain
approxim
f
tularensi
shcu
incub
min
fig
min
fig
contrast
control
sampl
incub
time
heat
treatment
result
reveal
heat
treatment
min
min
complet
inactiv
f
tularensi
shcu
live
bacteria
detect
heattreat
sampl
minim
time
requir
heat
inactiv
f
tularensi
shcu
estim
viabl
bacteria
detect
incub
fig
shown
fig
live
bacteria
detect
cdm
cfu
undilut
fb
cfu
follow
heat
treatment
min
none
suspend
deioniz
water
pb
bacteria
detect
heattreat
sampl
min
fig
steril
filter
often
use
remov
contamin
bacteria
liquid
sampl
evalu
effect
filter
steril
f
tularensi
schu
ml
bacteri
suspens
cdm
averag
filtrat
use
steril
filter
emd
millipor
corpor
pore
emd
millipor
corpor
fig
filter
remov
viabl
bacteria
hand
small
number
bacteria
averag
detect
filtrat
filter
although
cfu
number
significantli
decreas
p
use
solut
ethanol
simpl
asept
techniqu
inactiv
pathogen
henc
relationship
ethanol
concentr
viabil
f
tularensi
schu
investig
bacteria
suspend
ethanol
incub
min
room
temperatur
centrifug
discard
ethanol
solut
afterward
cfu
number
pellet
calcul
preliminari
data
show
signific
chang
cfu
number
centrifug
fig
treatment
ethanol
min
viabl
bacteria
detect
fig
hand
cfu
number
treatment
ethanol
min
respect
fig
furthermor
incub
time
requir
inactiv
use
variou
concentr
ethanol
determin
bacteria
suspend
ethanol
rapidli
inactiv
within
fig
wherea
ethanol
surviv
incub
period
although
cfu
number
significantli
decreas
treatment
ethanol
p
organ
solvent
formalin
methanol
aceton
commonli
use
fix
infect
tissu
sampl
viabl
number
f
tularensi
schu
follow
treatment
variou
fixat
solut
determin
bacteria
spike
formalin
neutral
buffer
solut
pfa
methanol
aceton
mixtur
aceton
acetonitril
incub
min
room
temperatur
incub
period
sampl
centrifug
discard
solvent
viabl
bacteria
pellet
resuspend
cdm
count
shown
fig
viabl
bacteria
sampl
treat
organ
solvent
wherea
abund
bacteria
averag
cfu
found
control
sampl
effect
concentr
sodium
hypochlorit
inactiv
f
tularensi
schu
also
evalu
result
show
final
concentr
sodium
hypochlorit
suffici
inactiv
bacteria
signific
differ
bacteri
viabil
treat
control
sampl
p
deterg
use
wide
protein
extract
bacteria
infect
cell
studi
number
live
bacteria
detergenttr
control
sampl
compar
combin
condit
analysi
perform
use
three
incub
period
min
h
h
three
differ
deterg
lithium
dodecyl
sulphat
ld
buffer
nonidet
triton
three
solvent
deionis
water
cdm
rpmi
contain
fb
incub
sampl
centrifug
remov
deterg
solut
shown
mean
cfu
number
standard
deviat
sd
present
fig
sampl
complet
inactiv
although
cfu
number
sampl
treat
deterg
h
significantli
lower
control
sampl
p
bacteri
sampl
contain
deterg
subject
mechan
disrupt
use
bead
bacteria
suspend
cdm
undilut
fb
contain
fb
homogen
mean
cfu
number
sd
determin
shown
fig
averag
cfu
number
homogenis
cdm
undilut
fb
rpmi
contain
fb
ml
ml
ml
respect
bacteri
number
sampl
without
deterg
reduc
approxim
mechan
disrupt
mechan
disrupt
live
bacteria
detect
sampl
prepar
ld
buffer
contain
viabil
f
tularensi
schu
treatment
commerci
product
evalu
bacteri
pellet
cfu
suspend
cell
lysi
buffer
cell
signal
technolog
danver
usa
rlt
buffer
rneasi
mini
kit
qiagen
ltd
valencia
ca
usa
incub
min
room
temperatur
incub
abund
bacteria
sampl
treat
cell
lysi
buffer
none
sampl
treat
rlt
buffer
fig
uv
light
report
inactiv
bacteri
cell
via
thymin
dimer
format
reduct
viabl
f
tularensi
schu
uv
radiat
shown
fig
deioniz
water
cdm
live
bacteria
detect
uv
radiat
room
temperatur
undilut
fb
number
viabl
bacteria
ml
ml
tube
significantli
decreas
uv
radiat
complet
inactiv
f
tularensi
schu
achiev
fig
similarli
bacteria
undilut
fb
surviv
uv
radiat
room
temperatur
min
fig
hand
f
tularensi
schu
cell
spread
onto
eugon
chocol
agar
complet
inactiv
uv
radiat
evalu
whether
method
inactiv
f
tularensi
schu
describ
studi
would
applic
strain
francisella
cfu
treat
control
sampl
compar
use
five
strain
subsp
tularensi
nevada
subsp
holarctica
lv
kato
yama
kf
water
result
shown
fig
live
bacteria
detect
sampl
treatment
min
fig
black
bar
min
fig
gray
bar
filtrat
fig
gray
bar
ethanol
min
fig
black
bar
sodium
hypochlorit
fig
gray
bar
uv
radiat
deioniz
water
fig
cdm
fig
hand
live
bacteria
remain
suspens
filter
filter
strain
nevada
cfu
lv
cfu
kato
cfu
kf
water
cfu
although
differ
sensit
observ
among
strain
bacteria
found
surviv
deterg
treatment
fig
uv
radiat
undilut
fb
fig
f
tularensi
gramneg
nonsporeform
highli
pathogen
intracellular
bacterium
sampl
infect
f
tularensi
must
inactiv
complet
facil
transport
laboratori
lower
bsl
analys
bacteria
infect
cell
result
present
studi
show
f
tularensi
schu
readili
easili
inactiv
heat
treatment
min
min
filtrat
use
filter
treatment
ethanol
methanol
aceton
neutral
buffer
formalin
pfa
solut
hand
filtrat
use
filter
treatment
deterg
could
significantli
decreas
amount
live
f
tularensi
schu
insuffici
complet
remov
bacteria
f
tularensi
schu
suspend
undilut
fb
plastic
tube
resist
uv
radiat
deioniz
water
cdm
find
present
studi
similar
common
condit
bacteri
inactiv
actual
valu
inactiv
condit
f
tularensi
provid
detail
known
f
tularensi
surviv
long
period
soil
fodder
live
tick
anim
carcass
laboratori
cultur
media
f
tularensi
also
stabl
water
waterborn
outbreak
tularemia
caus
f
tularensi
subsp
holarctica
report
bulgaria
georgia
germani
itali
kosovo
norway
russia
sweden
turkey
czech
republ
republ
georgia
francisella
noatunensi
isol
diseas
atlant
cod
held
seawat
norway
suspend
steril
seawat
microcosm
cultur
bacteria
detect
day
studi
high
concentr
viabl
bacteria
detect
cdm
week
viabil
f
tularensi
schu
suspend
deioniz
water
undilut
fb
confirm
week
fig
data
indic
f
tularensi
remain
viabl
cdm
low
temperatur
agreement
find
previou
studi
addit
incub
within
h
affect
viabil
f
tularensi
schu
cfu
number
significantli
chang
min
h
deioniz
water
cdm
pb
fig
sera
plasma
sampl
collect
patient
anim
often
use
serolog
diagnosi
detect
specif
antibodi
agglutin
test
enzymelink
immunosorb
assay
indirect
immunofluoresc
western
blot
analysi
inactiv
complement
sampl
gener
incub
min
wide
known
mani
virus
nonsporul
bacteria
usual
inactiv
except
enterococci
thermophil
bacteria
studi
bacteria
detect
cdm
undilut
fb
follow
heat
treatment
min
fig
fig
moreov
bacteri
suspens
deioniz
water
quickli
inactiv
within
min
day
et
al
report
time
requir
reduc
popul
f
tularensi
lv
liquid
infant
formula
appl
juic
mango
juic
orang
juic
studi
f
tularensi
schu
cdm
undilut
fb
pb
respect
though
effici
inactiv
find
previou
data
seem
differ
francisella
viabil
heat
treatment
strongli
affect
solut
composit
accord
data
heat
treatment
min
suffici
inactiv
f
tularensi
semiperm
membran
filter
averag
pore
size
often
use
remov
bacteria
fungi
cell
aggreg
protein
debri
liquid
sampl
microbiolog
biomed
laboratori
separ
base
pore
size
membran
use
filter
membran
physic
removalsepar
mechan
chemic
inactiv
f
tularensi
diamet
rang
might
pass
membran
filter
averag
pore
size
surviv
filter
devic
filtrat
addit
filter
membran
easili
clog
sampl
fluid
contain
abund
aggreg
bacteria
larger
pore
size
filter
possibl
even
littl
pressur
accident
uncoupl
connect
syring
filter
therefor
leak
bacteria
filtrat
splash
bacteria
filtrat
paid
attent
filtrat
method
appli
use
ethanol
spray
simpl
asept
techniqu
effici
inactiv
nonsporul
bacteria
bacteri
spore
howev
effect
concentr
ethanol
wide
spectrum
microb
f
tularensi
schu
abl
resist
deactiv
solut
ethanol
least
min
although
viabil
significantli
reduc
fig
attempt
remov
f
tularensi
use
ethanol
solut
reduct
ethanol
concentr
along
incub
time
consid
depend
wavelength
uv
radiat
classifi
uva
nm
uvb
nm
uvc
nm
uvc
radiat
effect
induc
mutat
death
bacteri
well
mammal
cell
particular
uv
light
nm
near
maximum
absorb
dna
induc
accumul
dimer
adjac
thymidin
residu
dna
strand
rose
et
al
report
f
tularensi
lv
suspend
distil
water
inactiv
uvc
treatment
confirm
f
tularensi
schu
spread
onto
eugon
chocol
agar
complet
inactiv
uv
radiat
addit
bacteria
suspend
deioniz
water
cdm
ml
tube
ml
pcr
tube
easili
inactiv
uv
radiat
fig
hand
inactiv
bacteri
suspens
undilut
fb
difficult
uv
radiat
fig
suggest
uv
radiat
fail
inhibit
bacteria
solut
contain
abund
nutrient
includ
protein
bacillu
thuringiensi
b
anthraci
spore
effect
inactiv
uv
radiat
also
inhibit
nutrit
germin
condit
probabl
uv
radiat
unabl
inactiv
bacteria
solut
contain
abund
nutrient
absorb
uv
light
compound
f
tularensi
subsp
tularensi
schu
use
model
inactiv
f
tularensi
studi
parent
strain
f
tularensi
schu
virul
strain
initi
isol
foshay
ulcer
american
patient
ohara
research
laboratori
ohara
gener
hospit
fukushima
japan
obtain
strain
schu
rocki
mountain
laboratori
nation
institut
allergi
infecti
diseas
hamilton
mt
usa
afterward
f
tularensi
schu
attenu
passag
artifici
media
year
japan
virul
f
tularensi
schu
isol
vivo
passag
attenu
schu
describ
previou
report
believ
method
inactiv
f
tularensi
schu
describ
studi
would
applic
strain
francisella
viabil
treat
sampl
f
tularensi
schu
five
strain
similar
fig
actual
data
inactiv
f
tularensi
schu
present
report
howev
note
experi
perform
use
bacteri
suspens
bacteria
aggreg
sampl
condit
requir
complet
inactiv
might
differ
data
use
develop
effect
inactiv
procedur
howev
data
use
confirm
success
inactiv
procedur
recommend
studi
use
guid
laboratori
valid
procedur
laboratori
accord
current
us
japan
law
provid
appropri
perspect
data
report
although
alway
risk
infect
laboratori
worker
handl
f
tularensi
risk
control
compli
safeti
protocol
